The predictive value of next generation sequencing for matching advanced hepatocellular carcinoma patients to targeted and immunotherapy

The predictive value of next generation sequencing for matching advanced hepatocellular carcinoma patients to targeted and immunotherapy

BackgroundTargeted and Immunotherapy has emerged as a new first-line treatment for advanced hepatocellular carcinoma (aHCC). To identify the appropriate targeted and immunotherapy, we implemented next generation sequencing (NGS) to provide predictive and prognostic values for aHCC patients.MethodsPr...

Full description

Bibliographic Details
Main Authors: Jiajia Du, Erlei Zhang, Zhiyong Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Immunology
Subjects:
hepatocellular carcinoma
prognosis
NGS
immunotherapy
PD-L1
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1358306/full

Similar Items

Similar Items